Research and Markets (http://www.researchandmarkets.com/research/qp2dcj/countryfocus)
has announced the addition of the "CountryFocus:
Healthcare, Regulatory and Reimbursement Landscape - Mexico"
report to their offering.
The population of Mexico was approximately 118.8 million in 2013, and is
estimated to grow at a Compound Annual Growth Rate (CAGR) of 1.8%, to
approximately 128.6 million in 2020. This is due to a positive balance
between the birth and mortality rates. The government has been
successful in implementing the steps necessary for achieving universal
healthcare coverage, such as reforms in the System of Social Protection
in Health (Sistema de Protección Social en Salud).
The value of the Mexican pharmaceutical market amounted to $14 billion,
in 2013, and is expected to icrease at a CAGR of 7% to reach
approximately $22.5 billion in 2020. The medical device market was worth
$3.6 billion in 2013 and is projected to reach $5.4 billion in 2020, at
a CAGR of 6.1%. These positive growth trends can be attributed primarily
to government initiatives in the public healthcare sector and an
improved and updated regulatory environment.
Key Topics Covered:
1 Tables & Figures
3 Overview of the Pharmaceutical and Medical Device Markets
4 Market Access
5 Country Analysis
6 Opportunities and Challenges
For more information visit http://www.researchandmarkets.com/research/qp2dcj/countryfocus
[ Back To NFVZone's Homepage ]